EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergy Prediction of Lung Cancer Targeted Drugs Fusing Transcriptomic Data and Graph Networks

Pierre Martin, Sarah Becker, Alessandro Ferrari

American Journal Of Chemistry And Chemical Engineering · 28.02.2026 · 7 (1) · 1-13

DOI: 10.71465/ajcce3597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal Of Chemistry And Chemical Engineering, online erschienen am 28.02.2026. Verfasst von Pierre Martin und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains the leading cause of cancer-related mortality worldwide, necessitating the development of advanced therapeutic strategies. Combination therapy, the administration of two or more drugs, has emerged as a critical approach to overcome drug resistance and enhance therapeutic efficacy compared to monotherapy. However, experimental screening of all possible drug combinations is cost-prohibitive and time-consuming due to the combinatorial explosion of potential pairs. In this study, we propose a novel deep learning framework that predicts drug synergy specifically for lung cancer by fusing transcriptomic data with graph neural networks. The model integrates the chemical structural information of drugs, captured through graph convolutional networks, with the genomic features of cancer cell lines derived from high-throughput transcriptomic profiles. By employing an attention-based fusion mechanism, the architecturedynamically weighs the importance of molecular substructures and gene expression signatures to predict synergy scores. We evaluated our model on large-scale benchmark datasets, demonstrating superior performance over state-of-the-art machine learning baselines. The results indicate that incorporating cell-line-specific transcriptomic data significantly improves prediction accuracy, offering a promising computational tool to accelerate the discovery of effective combination therapies for non-small cell lung cancer and small cell lung cancer subtypes.

Zitieren

APA

Martin, P., Becker, S., & Ferrari, A. (2026). Synergy Prediction of Lung Cancer Targeted Drugs Fusing Transcriptomic Data and Graph Networks. American Journal Of Chemistry And Chemical Engineering, 7(1), 1-13. https://doi.org/10.71465/ajcce3597

Vancouver

Martin P, Becker S, Ferrari A. Synergy Prediction of Lung Cancer Targeted Drugs Fusing Transcriptomic Data and Graph Networks. American Journal Of Chemistry And Chemical Engineering. 2026;7(1):1-13. doi:10.71465/ajcce3597

BibTeX
@article{Martin2026,
  author = {Martin, Pierre and Becker, Sarah and Ferrari, Alessandro},
  title = {Synergy Prediction of Lung Cancer Targeted Drugs Fusing Transcriptomic Data and Graph Networks},
  journal = {American Journal Of Chemistry And Chemical Engineering},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {1--13},
  doi = {10.71465/ajcce3597}
}
Kostenlos starten →